£73.46

Humana Haploidentical Stem Cell Transplantation: An Emerging Treatment Modality (Stem Cell Biology and Regenerative Medicine)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£73 today · all-time low £73 (Feb 2026) · usually £75

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£75.33 £72.82 £73.37 £73.92 £74.46 £75.01 £75.56 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 3 price levels

Days at Price
Current Price
21 days · current 4 days 65 days 0 16 33 49 65 £73 £74 £75 Days at Price

Price Analysis

Most common price: £75 (65 days, 72.2%)

Price range: £73 - £75

Price levels: 3 different prices over 90 days

Description

Product Description This book discusses the aspects of haploidentical transplants and will shed light on the debates and questions on this burgeoning field and timely topic. Donor selection, graft failure, minimal CD34+ cell requirement, and conditioning regimens used for haploidentical transplants will be written by expert authors dealing with this type of transplants. Approximately one third of the books' chapters cover logic and basic aspects; the remaining two thirds of the book discuss clinical aspects, outcomes, and future perspectives, thus providing a comphrensive discussion of the topic. Haploidentical transplantation is extremely timely, rapidly-changing area and increasing its use will decrease the need for time-consuming, expensive, unrelated donor search. Moreover, Haploidentical Stem Cell Transplantation brings a set of clear answers to questions of feasibility, advantages over unrelated transplants, cost effectivity and outcome..  From the Back Cover This book discusses the aspects of haploidentical transplants and will shed light on the debates and questions on this burgeoning field and timely topic. Donor selection, graft failure, minimal CD34+ cell requirement, and conditioning regimens used for haploidentical transplants will be written by expert authors dealing with this type of transplants. Approximately one third of the books' chapters cover logic and basic aspects; the remaining two thirds of the book discuss clinical aspects, outcomes, and future perspectives, thus providing a comphrensive discussion of the topic. Haploidentical transplantation is extremely timely, rapidly-changing area and increasing its use will decrease the need for time-consuming, expensive, unrelated donor search. Moreover,  Haploidentical Stem Cell Transplantation brings a set of clear answers to questions of feasibility, advantages over unrelated transplants, cost effectivity and outcome..  About the Author Dr. Taner Demirer, MD, FACP, graduated from Ankara University Medical School in Turkey in 1984 and was trained in the USA through 1987-1997.  He completed his Internal Medicine residency at the Medical College of Wisconsin in 1989-1992 and hematology/oncology and bone marrow transplant fellowship at the University of Washington, Fred Hutchinson Cancer Research Center (FHCRC) in Seattle, in 1992-1997. He was trained under Professors Don Thomas (Nobel laureate), Dean Buckner, Frederick Appelbaum and Rainer Storb in the clinical division of FHCRC.   He is a diplomate of the American Board of Internal Medicine and Board certified in Internal Medicine and Medical Oncology.  He was given the title of ‘Fellow of American College of Physicians (FACP) by ACP in July 1996.  He has conducted many clinical studies at the FHCRC  as principal investigator or co-investigator mainly related to peripheral blood stem cell (PBSC)  mobilization and high-dose chemotherapy (HDC) as well as autologous or allogeneic stem cell transplantations (SCT) in patients with solid tumors and hematologic malignancies.  During his career he has written many papers in the respected medical journals and books in regard to PBSC mobilization kinetics, factors influencing the PBSC collection and engraftment and allogeneic as well as autologous SCT in patients with hematologic malignancies and solid tumors.  He was chairman of the EBMT Solid Tumors Working Party (STWP) in between 2001-2007. He has conducted, chaired and published studies in related to HDC in patients with solid tumors at the EBMT STWP.  He was also board member of the Federation of the European Cancer Societies (FECS) on behalf of the EBMT through 2001-2007.  He was the president of the 29th and 41st EBMT Annual Meetings which were held in Istanbul in 2003 and 2015. He has been member of the editorial board of several international journals.  Dr. Demirer is ,currently, a professor of medicine and hematology/oncology at the Ankara University Medical School in Ankara, Turke

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Stem Cells and Cancer Stem Cells, Volume 12: Therapeutic Applications in Disease and Injury
77% match

Stem Cells and Cancer Stem Cells, Volume 12: Therapeutic Applications in Disease and Injury

Springer

£107.98 18 May 2026
Hematopoietic Stem Cell Biology (Stem Cell Biology and Regenerative Medicine)
77% match

Hematopoietic Stem Cell Biology (Stem Cell Biology and Regenerative Medicine)

Humana

£80.64 18 May 2026
Multipotent Stem Cells of the Hair Follicle: Methods and Protocols: 1453 (Methods in Molecular Biology, 1453)
77% match

Multipotent Stem Cells of the Hair Follicle: Methods and Protocols: 1453 (Methods in Molecular Biology, 1453)

Humana

£69.34 18 May 2026
Tumor Microenvironment: Hematopoietic Cells – Part B: 1273 (Advances in Experimental Medicine and Biology, 1273)
77% match

Tumor Microenvironment: Hematopoietic Cells – Part B: 1273 (Advances in Experimental Medicine and Biology, 1273)

Springer

£107.98 18 May 2026
Hematopoietic Stem Cell Protocols: 1185 (Methods in Molecular Biology, 1185)
77% match

Hematopoietic Stem Cell Protocols: 1185 (Methods in Molecular Biology, 1185)

Humana

£80.64 18 May 2026
Experimental and Applied Immunotherapy
77% match

Experimental and Applied Immunotherapy

Humana

£140.31 04 May 2026
Stem Cell Biology in Health and Disease
77% match

Stem Cell Biology in Health and Disease

Springer

£112.93 11 May 2026
Human Embryonic Stem Cells
77% match

Human Embryonic Stem Cells

Humana

£110.47 18 May 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
76% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£103.24 18 May 2026
Ex Vivo Engineering of the Tumor Microenvironment (Cancer Drug Discovery and Development)
76% match

Ex Vivo Engineering of the Tumor Microenvironment (Cancer Drug Discovery and Development)

Humana

£106.16 18 May 2026
Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)
76% match

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)

Humana

£80.64 18 May 2026
76% match

Decellularization Technology in Regenerative Medicine and Tissue Bioengineering (Regenerative and Transplant Medicine)

Academic Press

£157.99 11 May 2026
Tissue Stem Cells
76% match

Tissue Stem Cells

CRC Press

£62.39 18 May 2026
Liver Transplantation: Challenging Controversies and Topics (Clinical Gastroenterology)
76% match

Liver Transplantation: Challenging Controversies and Topics (Clinical Gastroenterology)

Humana

£84.60 18 May 2026
Stem Cell Therapy in Lysosomal Storage Diseases (Stem Cell Biology and Regenerative Medicine)
76% match

Stem Cell Therapy in Lysosomal Storage Diseases (Stem Cell Biology and Regenerative Medicine)

Humana

£80.41 18 May 2026
Autologous Stem Cell Transplantation: Biological and Clinical Results in Malignancies (Advances in Blood Disorders, 2)
76% match

Autologous Stem Cell Transplantation: Biological and Clinical Results in Malignancies (Advances in Blood Disorders, 2)

Routledge

£87.05 18 May 2026
Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)
75% match

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Humana

£95.70 18 May 2026
Immunodeficiency, Infection, and Stem Cell Transplantation, An Issue of Hematology/Oncology Clinics of North America (Volume 25-1) (The Clinics: Internal Medicine, Volume 25-1)
75% match

Immunodeficiency, Infection, and Stem Cell Transplantation, An Issue of Hematology/Oncology Clinics of North America (Volume 25-1) (The Clinics: Internal Medicine, Volume 25-1)

Saunders

£54.69 18 May 2026
Regenerative Therapy Using Blood-Derived Stem Cells (Stem Cell Biology and Regenerative Medicine)
75% match

Regenerative Therapy Using Blood-Derived Stem Cells (Stem Cell Biology and Regenerative Medicine)

Humana

£80.64 04 May 2026
Adult Stem Cells (Stem Cell Biology and Regenerative Medicine)
75% match

Adult Stem Cells (Stem Cell Biology and Regenerative Medicine)

Humana

£107.85 18 May 2026
Stem Cells and Cancer Stem Cells, Volume 6: Therapeutic Applications in Disease and Injury
75% match

Stem Cells and Cancer Stem Cells, Volume 6: Therapeutic Applications in Disease and Injury

Springer

£147.99 11 May 2026
Hematopoietic Stem Cell Development (Medical Intelligence Unit)
75% match

Hematopoietic Stem Cell Development (Medical Intelligence Unit)

Springer

£106.68 18 May 2026
Aplastic Anemia and Other Bone Marrow Failure Syndromes
75% match

Aplastic Anemia and Other Bone Marrow Failure Syndromes

Springer

£77.14 18 May 2026
Regenerative Medicine for Degenerative Muscle Diseases (Stem Cell Biology and Regenerative Medicine)
75% match

Regenerative Medicine for Degenerative Muscle Diseases (Stem Cell Biology and Regenerative Medicine)

Humana

£103.24 18 May 2026